510(k) Report

510(k) · Cleared

Cleared

Puregraft 50 System

K132815510(k) TraditionalCleared Jan 24, 2014137-day reviewClass II21 CFR 878.5040

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cytori Therapeutics, Inc. · MUU System, Suction, Lipoplasty

Cleared on Jan 24, 2014 as substantially equivalent to K092923 (Cytori Therapeutics, Inc., 2010) and 1 other predicate after a 137-day review. Its family tree reaches back 9 generations to 1991.

Decided
Jan 24, 2014
Review
137 days
Class
Class II
Product code
MUU
Recalls
None
Predicates
2

Its longest line of descent runs back 9 generations to K910696 (1991). 32 ancestors in all, the oldest K861153 (1986). No later device cites it as a predicate yet.

  1. Root · 9 generations backK910696 Cusa (R) System 200C/200T/200M/200H Ultra AspiratorValleylab, Inc. · 1991
  2. 5 generations between
  3. 3 generations backK081848 Lipose Fat Transfer SystemLipose Corp. · 2008
  4. 2 generations backK092923 Cytori Puregraft 250/Pure SystemCytori Therapeutics, Inc. · 2010
  5. 1 generation backK113255 Puregraft 850/Pure SystemCytori Therapeutics, Inc. · 2012
  6. This deviceK132815 Puregraft 50 SystemCytori Therapeutics, Inc. · 2014
Show all 9 generations
  1. Root · 9 generations backK910696 Cusa (R) System 200C/200T/200M/200H Ultra AspiratorValleylab, Inc. · 1991
  2. 8 generations backK970471 Mentor Ultrasound Assisted Tissue Removal System (TRS)Mentor Corp. · 1997
  3. 7 generations backK983065 Mentor Ultrasound-Assisted Tissue Removal SystemMentor Corp. · 1998
  4. 6 generations backK022051 Soundvaser SystemSound Surgical Technologies, LLC · 2002 · Recalled
  5. 5 generations backK042261 Macropore Puricel Lipoplasty SystemMacropore Biosurgery, Inc. · 2004
  6. 4 generations backK072587 Cytori Aft SystemCytori Therapeutics, Inc. · 2007
  7. 3 generations backK081848 Lipose Fat Transfer SystemLipose Corp. · 2008
  8. 2 generations backK092923 Cytori Puregraft 250/Pure SystemCytori Therapeutics, Inc. · 2010
  9. 1 generation backK113255 Puregraft 850/Pure SystemCytori Therapeutics, Inc. · 2012
  10. This deviceK132815 Puregraft 50 SystemCytori Therapeutics, Inc. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K910696Cusa (R) System 200C/200T/200M/200H Ultra AspiratorValleylab, Inc.1991—
−8K970471Mentor Ultrasound Assisted Tissue Removal System (TRS)Mentor Corp.1997—
−7K983065Mentor Ultrasound-Assisted Tissue Removal SystemMentor Corp.1998—
−6K022051Soundvaser SystemSound Surgical Technologies, LLC20022
−5K042261Macropore Puricel Lipoplasty SystemMacropore Biosurgery, Inc.2004—
−4K072587Cytori Aft SystemCytori Therapeutics, Inc.2007—
−3K081848Lipose Fat Transfer SystemLipose Corp.2008—
−2K092923Cytori Puregraft 250/Pure SystemCytori Therapeutics, Inc.2010—
−1K113255Puregraft 850/Pure SystemCytori Therapeutics, Inc.2012—
0 (this device)K132815Puregraft 50 SystemCytori Therapeutics, Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198620
198820
199210
199410
199520
199620
199720
199840
199940
200110
200510
200610
FIG. 1 — Lineage of K132815, 1991–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MUU? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MUU device

  1. #1 K210528 IntelliFat Disposable Adipose Tissue…score 5.7 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K092923Cytori Puregraft 250/Pure System
Summary page 3
…les with the following predicate devices which have been determined by FDA to be substantially equivalent to a premarket device: the Cytori Puregraft® 250/PURE System (K092923), and Puregraft 850/PURE System (KI 13255); both are a Class 11 medical device that have been cleared for marketing in the Unite…
Cytori Therapeutics, Inc.2010—
*K113255Puregraft 850/Pure System
Summary page 3
…body contouring. Design and Materials The design and materials of the Puregraft 50 System and the Puregraft 250/PURE System (K092923) and Puregraft 850/PURE System (KI 113255) are substantially equivalent as they are all single-use, polymer constructed, manually operated systems that receive adipose tis…
Cytori Therapeutics, Inc.2012—

Also cleared against K092923: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 6 companies; a new generation was cleared every 2.0 years on median.
  • 4 of the 32 ancestors have a recall of any class.
  • 1 other device also cites its predicate K092923.

How does its category compare?

All MUU devices

MUU System, Suction, Lipoplasty: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · MUU

1in 2022

2007: 12008: 12009: 32010: 42012: 52013: 12014: 42015: 32016: 12017: 72018: 12019: 42020: 22021: 22022: 1
2007high 7 (2017) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MUU

190in 2019

2009: 113 days median2010: 58 days median2012: 171 days median2014: 114 days median2015: 269 days median2017: 91 days median2019: 190 days median
2007high 269 (2015) · low 58 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MUU

2in 2017

2007: 12015: 12016: 12017: 2
2007high 2 (2017) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MUU

10in 2025

2007: 22008: 42009: 22010: 42011: 52012: 42013: 212014: 132015: 442016: 202017: 282018: 302019: 352020: 362021: 282022: 502023: 152024: 52025: 10
2007high 50 (2022) · low 2 (2007)2025

MAUDE reports naming product code MUU, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—12
20081—04
2009311302
201045804
20110—05
2012517104
20131—021
20144114013
20153269144
20161—120
2017791228
20181—030
20194190035
20202—036
20212—028
20221—050
20230—015
20240—05
20250—010
20260—0—

What is it indicated for?

The Puregraft 50 System is indicated for use in the harvesting, filtering and transferring of autologous fat tissue for reinjecting back into the same patient for aesthetic body contouring.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K132815: Puregraft 50 System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K132815

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026